Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreous Ranibizumab for Trabeculectomy in Neovascular Glaucoma
NCT01922154Phase 4Completed
- Sponsor
- Siriraj Hospital
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in neovascular glaucoma (NVG), sponsored by Siriraj Hospital. Started Feb 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
neovascular glaucoma (NVG)
Beyond the preview
Go deeper on NCT01922154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922154.